Theralase Technologies (TSXV TLT) Revenue and Competitors
Estimated Revenue & Valuation
- Theralase Technologies (TSXV TLT)'s estimated annual revenue is currently $2.9M per year.
- Theralase Technologies (TSXV TLT)'s estimated revenue per employee is $100,500
Employee Data
- Theralase Technologies (TSXV TLT) has 29 Employees.
- Theralase Technologies (TSXV TLT) grew their employee count by 7% last year.
Theralase Technologies (TSXV TLT)'s People
| Name | Title | Email/Phone |
|---|
Theralase Technologies (TSXV TLT) Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $18.5M | 92 | -1% | N/A | N/A |
#2 | $14.3M | 71 | 6% | N/A | N/A |
#3 | $36M | 179 | 8% | N/A | N/A |
#4 | $7.8M | 39 | 8% | N/A | N/A |
#5 | $17.9M | 93 | 3% | $192.2M | N/A |
#6 | $64.9M | 323 | 4% | N/A | N/A |
#7 | $0.5M | 5 | -55% | N/A | N/A |
#8 | $6.8M | 34 | -41% | N/A | N/A |
#9 | $19.5M | 97 | 23% | N/A | N/A |
#10 | $2.5M | 25 | 19% | N/A | N/A |
What Is Theralase Technologies (TSXV TLT)?
Theralase® Technologies is a Canadian clinical stage pharmaceutical company dedicated to the research and development of light activated Photo Dynamic Compounds and their associated drug formulations intended to safely and effectively destroy various cancers. We strive to continuously improve the quality of life for those afflicted with cancer by focusing our research and development on preventing, alleviating and treating diseases. Serving our higher purpose to bring hope for cancer treatments to light.Founded in 1994, Theralase’s operations are divided into two divisions: the production of therapeutic laser technology for commercial applications, and the research and development of laser-based technologies for the destruction of cancer cells and other disease states. Theralase® is focused on the discovering, developing and aiming for commercialization of Anti-Cancer therapies using light-activated PhotoDynamic Compounds and their associated drug formulations to safely and effectively treat patients afflicted with cancer.
keywords:N/A
N/A
Total Funding
29
Number of Employees
$2.9M
Revenue (est)
7%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Other Companies in Toronto
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $2.4M | 29 | -9% | N/A |
#2 | $6.6M | 29 | -9% | N/A |
#3 | $2.9M | 29 | 0% | N/A |
#4 | $5M | 29 | -29% | N/A |
#5 | $6.7M | 29 | -33% | N/A |